Séverine Planel

Séverine PLANEL has been working in the scientific field since 2005. Séverine began their career as a Chercheur en Thèse at INSERM-CEA de Grenoble, where they developed a therapeutic protein-based anti-tumor therapy. In 2009, they became a Chercheur Post-Doctorant at Sanofi-aventis and participated in the organization of BioVision-Next 2013 and the Journée de Rencontre sur la Recherche Translationnelle in 2012. Séverine also obtained the Prize of Business Model 2012 at the Startup Weekend OpenLabs and participated in the organization of the Journée BIOTechno 2011. In 2013, they became a Chef de Projet R&D at bioMérieux (CDD) and in 2014, they became the Référente Immunomonitoring - Analyse Cellulaire et Immuno-essais at BIOASTER. Currently, they are a Senior Scientist at PDC*line Pharma.

Séverine PLANEL obtained their Doctorat (PharmD) in Pharmacie from Université Claude Bernard Lyon 1 between 1996 and 2003. Séverine then went on to pursue their Doctorat (PhD) in Biologie Moléculaire et Cellulaire from Université Joseph Fourier (Grenoble I) between 2005 and 2008.